Dentsply Sirona (XRAY) Net Income towards Common Stockholders (2009 - 2026)
Dentsply Sirona (XRAY) reported Net Income towards Common Stockholders of -$10.0 million for Q1 2026, down 152.63% on a YoY basis from $19.0 million in Q1 2025, and up 93.1% quarter-over-quarter from -$145.0 million in Q4 2025.
Dentsply Sirona (XRAY) Net Income towards Common Stockholders (2009 - 2026) Analysis & Trends
Dentsply Sirona has reported Net Income towards Common Stockholders for 18 years, with the latest figure at -$10.0 million in Q1 2026.
- For the quarter ending Q1 2026, Net Income towards Common Stockholders fell 152.63% year-over-year to -$10.0 million; the trailing twelve-month figure through Mar 2026 stood at -$627.0 million (up 30.95% YoY), and the FY2025 full-year result was -$598.0 million, up 34.29% from the prior year.
- Net Income towards Common Stockholders for Q1 2026 stood at -$10.0 million, up from -$145.0 million in the prior quarter.
- The five-year high for Net Income towards Common Stockholders was $85.0 million in Q2 2023, with the low at -$1.1 billion in Q3 2022.
- Historically, Net Income towards Common Stockholders has averaged -$152.9 million across 5 years, with a median of -$15.0 million in 2022.
- Annual changes were most pronounced in 2022 — Net Income towards Common Stockholders slumped 1382.14% — and 2023, when it soared 580.0%.
- Dentsply Sirona's Net Income towards Common Stockholders stood at -$15.0 million in 2022, then soared by 580.0% to $72.0 million in 2023, then slumped by 694.44% to -$428.0 million in 2024, then surged by 66.12% to -$145.0 million in 2025, then surged by 93.1% to -$10.0 million in 2026.
- The last three Net Income towards Common Stockholders figures came in at -$10.0 million (Q1 2026), -$145.0 million (Q4 2025), and -$428.0 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | 826.00 Mn |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | -274.00 Mn |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | 239.00 Mn |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | 398.73 Mn |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | 135.40 Mn |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | 13.00 Mn |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | -77.90 Mn |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | 112.77 Mn |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | 2.00 Mn |
| 10 | Dentsply Sirona | 2.09 Bn | 1.90 Bn | 427.00 Mn | -10.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -10.00 Mn |
| Dec 31, 2025 | -145.00 Mn |
| Sep 30, 2025 | -428.00 Mn |
| Jun 30, 2025 | -44.00 Mn |
| Mar 31, 2025 | 19.00 Mn |
| Dec 31, 2024 | -428.00 Mn |
| Sep 30, 2024 | -495.00 Mn |
| Jun 30, 2024 | -4.00 Mn |
| Mar 31, 2024 | 17.00 Mn |
| Dec 31, 2023 | 72.00 Mn |
| Sep 30, 2023 | -266.00 Mn |
| Jun 30, 2023 | 85.00 Mn |
| Mar 31, 2023 | -23.00 Mn |
| Dec 31, 2022 | -15.00 Mn |
| Sep 30, 2022 | -1.08 Bn |
| Jun 30, 2022 | 73.00 Mn |
| Mar 31, 2022 | 69.00 Mn |
| Dec 31, 2021 | 119.00 Mn |
| Sep 30, 2021 | 84.00 Mn |
| Jun 30, 2021 | 93.00 Mn |